IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 294 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $269,000 | -11.8% | 5,680 | +9.9% | 0.01% | -16.7% |
| Q2 2020 | $305,000 | +5.5% | 5,170 | -15.5% | 0.01% | -14.3% |
| Q1 2020 | $289,000 | -8.0% | 6,121 | +17.6% | 0.01% | 0.0% |
| Q4 2019 | $314,000 | +5.7% | 5,205 | +4.9% | 0.01% | 0.0% |
| Q3 2019 | $297,000 | -16.1% | 4,961 | -10.1% | 0.01% | -30.0% |
| Q2 2019 | $354,000 | -7.1% | 5,517 | +17.6% | 0.01% | -9.1% |
| Q1 2019 | $381,000 | +12.4% | 4,693 | -25.2% | 0.01% | 0.0% |
| Q4 2018 | $339,000 | -7.4% | 6,272 | -11.6% | 0.01% | 0.0% |
| Q3 2018 | $366,000 | +23.6% | 7,096 | -0.1% | 0.01% | +22.2% |
| Q2 2018 | $296,000 | -2.0% | 7,104 | +3.8% | 0.01% | -10.0% |
| Q1 2018 | $302,000 | -13.2% | 6,841 | -1.1% | 0.01% | -9.1% |
| Q4 2017 | $348,000 | -1.4% | 6,920 | -0.5% | 0.01% | -15.4% |
| Q3 2017 | $353,000 | +4.7% | 6,954 | +4.8% | 0.01% | 0.0% |
| Q2 2017 | $337,000 | +67.7% | 6,633 | +32.7% | 0.01% | +62.5% |
| Q1 2017 | $201,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,463,400 | $418,566,000 | 6.01% |
| Tweedy, Browne Co LLC | 2,722,988 | $120,438,000 | 5.30% |
| BVF INC/IL | 2,872,953 | $127,071,000 | 5.25% |
| Sicart Associates LLC | 253,976 | $11,233,000 | 3.98% |
| Parkman Healthcare Partners LLC | 241,945 | $10,701,000 | 3.04% |
| Camber Capital Management LP | 1,925,000 | $85,143,000 | 2.61% |
| Privium Fund Management B.V. | 148,807 | $6,589,000 | 2.39% |
| SECTOR GAMMA AS | 164,223 | $7,264,000 | 1.87% |
| HANSEATIC MANAGEMENT SERVICES INC | 10,993 | $486,000 | 1.31% |
| BRANDYWINE MANAGERS, LLC | 8,460 | $374,000 | 1.23% |